unknown by C Psarros
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Annals of General Hospital 
Psychiatry
Open AccessOral presentation
Atypical antipsychotic medication in the treatment of 
bipolar affective disorders
C Psarros*
Address: Lecturer in Psychiatry, Eginition Hospital, University of Athens, Greece
* Corresponding author    
Several mood stabilizers, such as lithium, valproic acid
and carbamazepine are widely used for the prevention
and treatment of bipolar disorders. However, there is
number of patients unresponsive to either monotherapy
or combination treatment. This proportion may be even
higher in patients with mixed episodes or rapid cycling.
Conventional antipsychotics have been used over four
decades to treat bipolar disorders, especially those with
psychotic features. It has been reported that they may
induce or exacerbate major depressive episodes, while
high incidence of extrapyramidal side effects has also been
noted. Furthermore, literature review suggests that their
long-term use may be related to poor functioning. Atypi-
cal antipsychotics characterized by a much-improved tol-
erability and safety profile can be used as an adjunctive
therapy for psychotic bipolar patients or as alternatives for
the treatment of bipolar patients with mania who have
not responded to lithium or other mood stabilizers. It has
been demonstrated that olanzapine monotherapy is effi-
cacious in the treatment of acute mania. Certain atypical
antipsychotics may possess antidepressant effects as add-
on therapy in patients with mood disorders. The existing
literature suggests their long-term use in low doses as
adjunctive treatments of mood stabilizing agents in severe
refractory patients. The issue of efficacy and tolerability of
atypical antipsychotics alone or in combination with
mood stabilizers in bipolar disorders is critical, challeng-
ing and warrants further exploration in the context of
larger controlled studies.
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